Inventor · disambiguated record
Yoshio Aramaki
Also filed as: ARAMAKI YOSHIO
10 granted patents·1 pending application·195 citations·filing 1992–2006
90Inventor score
Top patents by PatentIndex Score
11 records- 0190US6268354B1Pharmaceutical composition for antagonizing CCR5 comprising anilide derivativeTAKEDA CHEMICAL INDUSTRIES LTD·Filed 2000·Granted Jul 31, 2001·39 cites·21 claims
- 0290US5420275APyridopyridazine compounds and their useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1993·Granted May 30, 1995·52 cites·5 claims
- 0381US6376536B1Quaternary ammonium salts and their useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 2000·Granted Apr 23, 2002·12 cites·7 claims
- 0479US6936602B1Benzazepine derivatives, process for the preparation of the same and uses thereofTAKEDA CHEMICAL INDUSTRIES LTD·Filed 2000·Granted Aug 30, 2005·12 cites·27 claims
- 0578US6166006AAnilide derivative, production and use thereofTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1998·Granted Dec 26, 2000·20 cites·26 claims
- 0676US7262185B2Benzazepine derivative, process for producing the same, and useTAKEDA PHARMACEUTICAL·Filed 2002·Granted Aug 28, 2007·6 cites·17 claims
- 0776US6413947B1Anilide derivative, production and use thereofTAKEDA CHEMICAL INDUSTRIES LTD·Filed 2000·Granted Jul 2, 2002·8 cites·18 claims
- 0875US6096780AQuaternary ammonium salts and their useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1999·Granted Aug 1, 2000·35 cites·22 claims
- 0950US6172061B1Pharmaceutical composition for antagonizing CCR5 comprising anilide derivativeTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1998·Granted Jan 9, 2001·11 cites·37 claims
- 1041US2010130737A1Regulating Agent of GPR34 Receptor FunctionTAKEDA PHARMACEUTICAL·Filed 2006·Application pending·0 cites
- 1117US5246968AGlutamate receptor inhibitorTAKEDA CHIMICAL IND LTD·Filed 1992·Granted Sep 21, 1993·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Yoshio Aramaki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →